Gene Therapy & Gene Editing
Part of Healthcare - Genomics & Precision Medicine
 VRTX | Vertex Pharmaceuticals Inc | $119.5b | $486.56 | -0.2% | 731.4K |
 REGN | Regeneron Pharmaceuticals Inc | $78.2b | $767.67 | +0.4% | 327.6K |
 INSM | Insmed, Inc. | $21.4b | $131.92 | +33.9% | 11.3M |
 BMRN | BioMarin Pharmaceuticals Inc | $11.6b | $64.42 | +2.6% | 2.8M |
 KRYS | Krystal Biotech, Inc. Common Stock | $10.1b | $322.25 | -0.9% | 140.1K |
 CRSP | CRISPR Therapeutics AG | $4.7b | $51.64 | -1.6% | 836.3K |
 FOLD | Amicus Therapeutics, Inc | $4.5b | $14.49 | +0.0% | 3.5M |
 QURE | uniQure N.V. | $3.1b | $46.79 | +2.7% | 1.1M |
 BEAM | Beam Therapeutics Inc. Common Stock | $2.6b | $27.45 | +0.6% | 964.0K |
 VCEL | Vericel Corporation | $2.4b | $44.73 | -1.3% | 255.8K |
 PGEN | Precigen, Inc. Common Stock | $2.4b | $6.99 | +0.1% | 6.1M |
 SRPT | Sarepta Therapeutics,, Inc. Common Stock | $1.7b | $16.77 | +5.3% | 3.7M |
 TSHA | Taysha Gene Therapies, Inc. Common Stock | $1.7b | $6.40 | -1.9% | 1.7M |
 BLFS | BioLife Solutions Inc. | $1.5b | $33.15 | +0.3% | 382.4K |
 NTLA | Intellia Therapeutics, Inc | $1.5b | $11.58 | +2.5% | 3.8M |
 MGTX | MeiraGTx Holdings plc Ordinary Shares | $1.1b | $12.80 | +2.0% | 268.7K |
 PCRX | Pacira BioSciences, Inc. Common Stock | $1.1b | $26.38 | +2.9% | 733.3K |
 SANA | Sana Biotechnology, Inc. Common Stock | $0.9b | $3.37 | -2.8% | 1.5M |
 SLDB | Solid Biosciences Inc. Common Stock | $0.8b | $8.13 | -0.3% | 483.7K |
 DSGN | Design Therapeutics, Inc. Common Stock | $0.8b | $14.07 | +1.5% | 291.5K |
 CYRX | CryoPort, Inc. Common Stock | $0.8b | $15.39 | -3.7% | 560.7K |
 NGNE | Neurogene, Inc. Common Stock | $0.7b | $35.59 | -1.3% | 75.9K |
 ALLO | Allogene Therapeutics, Inc. Common Stock | $0.6b | $1.97 | +1.0% | 2.9M |
 RGNX | REGENXBIO Inc. | $0.6b | $11.43 | +7.4% | 1.6M |
 FDMT | 4D Molecular Therapeutics, Inc. Common Stock | $0.5b | $10.65 | +2.8% | 225.9K |
 PRME | Prime Medicine, Inc. Common Stock | $0.5b | $2.93 | -5.0% | 2.2M |
 KYTX | Kyverna Therapeutics, Inc. Common Stock | $443.8m | $7.76 | +1.6% | 447.3K |
 CABA | Cabaletta Bio, Inc. Common Stock | $437.0m | $2.75 | +2.2% | 2.5M |
 OCGN | Ocugen, Inc. Common Stock | $423.9m | $1.25 | -2.3% | 5.1M |
 BNTC | Benitec Biopharma Inc. Common Stock | $402.3m | $13.14 | +3.9% | 49.7K |
 EDIT | Editas Medicine, Inc. Common Stock | $395.9m | $2.88 | +5.6% | 3.2M |
 RCKT | Rocket Pharmaceuticals, Inc. Common Stock | $372.4m | $3.56 | +0.9% | 1.9M |
 ABEO | Abeona Therapeutics Inc. Common Stock | $365.9m | $6.93 | +1.5% | 773.1K |
 LXEO | Lexeo Therapeutics, Inc. Common Stock | $324.3m | $4.54 | +2.2% | 1.3M |
 IRD | Opus Genetics, Inc. Common Stock | $306.3m | $3.73 | -1.6% | 572.0K |
 TRDA | Entrada Therapeutics, Inc. Common Stock | $281.8m | $7.03 | -2.5% | 234.4K |
 VYGR | Voyager Therapeutics, Inc. Common Stock | $181.3m | $3.13 | +0.6% | 367.7K |
 DTIL | Precision BioSciences, Inc. Common Stock | $180.4m | $7.42 | -0.7% | 235.1K |
 TNYA | Tenaya Therapeutics, Inc. Common Stock | $158.2m | $0.75 | -7.5% | 2.9M |
 KRRO | Korro Bio, Inc. Common Stock | $149.6m | $12.13 | +5.9% | 131.3K |
 CBUS | Cibus, Inc. Class A Common Stock | $147.3m | $1.92 | -4.1% | 102.1K |
 CRBU | Caribou Biosciences, Inc. Common Stock | $144.8m | $1.63 | +1.9% | 788.7K |
 GNLX | Genelux Corporation Common Stock | $131.8m | $2.75 | +7.2% | 196.9K |
 ENGN | enGene Therapeutics Inc. Common Stock | $119.9m | $1.79 | 0.0% | 292.5K |
 MXCT | MaxCyte, Inc. Common Stock | $114.6m | $1.11 | +4.2% | 846.9K |
 SGMO | Sangamo Therapeutics, Inc. Common Stock | $83.3m | $0.18 | -17.5% | 6.9M |
 INO | Inovio Pharmaceuticals, Inc. | $55.7m | $0.67 | -1.6% | 1.7M |
 TIL | Instil Bio, Inc. Common Stock | $49.0m | $7.39 | 0.0% | 2.0K |
 TCRX | TScan Therapeutics, Inc. Common Stock | $47.3m | $0.78 | -1.8% | 126.0K |
 MGX | Metagenomi Therapeutics, Inc. Common Stock | $45.6m | $1.23 | +1.2% | 144.7K |